
Bioorganic and medicinal chemistry p. 6123 - 6133,11 (2012)
Update date:2022-08-03
Topics:
Tichy, Michal
Pohl, Radek
Hocek, Michal
Xu, Hao Ying
Chen, Yen-Liang
Yokokawa, Fumiaki
Shi, Pei-Yong
A series of new pyrimido[4,5-b]indole ribonucleosides bearing phenyl or hetaryl group at position 4 has been prepared by selective Pd-catalyzed cross-coupling reactions of the corresponding protected 4,6-dichloropyrimido[4, 5-b]indole ribonucleoside with (het)arylboronic acids or stannanes followed by deprotection. Further cross-couplings under harsher conditions and employing X-Phos ligand proceeded at the position 6 leading to 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides. Some of these compounds displayed antiviral activity against Dengue virus.
View MoreContact:0086-29-88315623
Address:S711, Innovation Bldg No.25 Gaoxin 1st Rd, Xian P.R of China 710075
website:https://www.finerchem.com
Contact:+86-531-88989536
Address:New Material Industrial Park, Jinan City, China
Jinan Aery Pharmaceutical Co,.Ltd
Contact:+8653181263406
Address:1-1916,Building1 Fenghuang SOHO,Fenghuang Road,High-tech Zone,Jinan,Shandong
Changsha Yihai Chemical Technology Co.,ltd
website:http://www.cs-yihai.com/
Contact:0731- 85620465
Address:Room 23005, unit 2, the northern building of Xiangsong international building , NO.259 Shaoshan Road , Changsha , Hunan, China.(mainland)
website:http://www.fwdchem.com
Contact:86-21-54450828
Address:Room 802,Lotus Tower ,159 Tianzhou Road,Xuhui District,Shanghai
Doi:10.1021/acs.orglett.1c00133
(2021)Doi:10.1021/jo01155a006
(1949)Doi:10.1007/BF00945332
()Doi:10.1021/acs.orglett.8b02701
(2018)Doi:10.1007/BF00779074
()Doi:10.1021/ja037223k
(2003)